OrbiMed’s Scribe Therapeutics SCTX Stock Holding History
Bought
Maintained
Sold
Other funds holding SCTX
BBA
OrbiMed's SCTX Position: Q3 2026 in Review
OrbiMed opened a new position in Scribe Therapeutics (SCTX) in Q3 2026: 1,348,825 shares worth $24.8M. The stake represents 0.45% of the portfolio and ranks #49 among its holdings.
62 funds tracked by Wall St. Rank hold SCTX as of Q3 2026.
- OrbiMed held 1,348,825 shares of Scribe Therapeutics worth $24.8M as of Q3 2026.
- Scribe Therapeutics was a new OrbiMed position in Q3 2026.
- Scribe Therapeutics made up 0.45% of OrbiMed's portfolio in Q3 2026, its #49 holding.
- 62 funds tracked by Wall St. Rank held Scribe Therapeutics as of Q3 2026.
Based on OrbiMed's 13F filing for Q3 2026, filed 16 Nov 2026.